BMC’s Center of Excellence in Sickle Cell Disease is the largest center of its kind in New England, serving more than 450 patients annually, from newborns to adults. The center’s multidisciplinary team is committed to providing patients with highly personalized care across childhood, teenage years, and adulthood. Our goal is to help patients manage their symptoms so they can live as normal a life as possible.
In addition to a designated pediatric sickle cell program and adult sickle cell program, our team offers a transitional care clinic to help young adults transition into adult care and learn how to play a role in their own health care.
Our team includes physicians and nurse practitioners from pediatric and adult hematology and primary care, as well as other specialties. Nurses, social workers, case management, and a patient navigator are also available to help guide patients through their care. Our team works with departments across the hospital to provide coordinated and consistent care between the Emergency Department, inpatient services, and outpatient clinics, including the pediatric STAR unit and the Infusion Center in the Adult Hematology/Oncology Clinic.
Highlights of our program include:
- Largest combined pediatric and adult sickle cell disease (SCD) center in New England
- A focus on research to learn how sickle cell disease affects the body and investigate new potential treatments
- Unique programs to help patients navigate the transition of care from pediatrics to adulthood
- Expertise in medical and surgical management of the complications of SCD
- Expertise in pain management
- A diverse team that speaks several languages, including Spanish and French, as well as translation services for 263 languages
Moakley Building 617.638.6428
Yawkey Center 617.414.4841
Sickle Cell Disease - Adult Clinic
Sickle Cell Disease - Pediatric Clinic
Sickle Cell Disease - Transitional Care
Conditions We Treat
Jean-Antoine Ribeil, MD, PhD, recently joined Boston Medical Center’s Department of Hematology and Oncology as clinical director of the Center of Excellence in Sickle Cell Disease. As an…
Athletes across the city are pumping up their tires and lacing up their shoes for the Boston Triathlon next weekend. Many are raising important dollars for critical programs at Boston Medical Center.
BMC researchers are finding innovative new ways to treat and cure blood disorders.
As our patient, you'll have access to a wide range of clinical trials from both BMC researchers and researchers at other institutions. While we enroll any and all eligible patients in clinical trials, BMC physicians are in particular leaders in the enrollment of under-represented minorities in clinical trials.
Latest from HealthCity
This year’s community stories touched on the overdose crisis, sickle cell disease, and the mental health toll of the COVID-19 pandemic
Inspired by their Aunt Winnie, the McCourty twins have made a cure for sickle cell disease a driving force of their life's work off the football field
BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.
Progress toward improving outcomes for adults with sickle cell disease hinges on more qualified, trained physicians and investment in research.
Structural racism has neglected advancements in SCD treatment. Novel therapies are on the horizon, but can they affordably be brought to the masses?
Comprehensive, multidisciplinary services that provide whole-person care can be difficult to find. Experts are changing that.
Respiratory viruses are known to cause severe complications in people with sickle cell disease, many of whom already face significant challenges.
Research from a sickle cell disease clinic hopes to shift the philosophy of subspecialty clinics to embrace a more holistic view of patient health.
Medical communities are improving treatment access for pediatric sickle cell disease by crowdsourcing expertise among clinicians.
A pilot program suggests ride-hailing services are an effective, low-cost solution for patients with transportation barriers.